Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1720451835;51836;51837 chr2:178609813;178609812;178609811chr2:179474540;179474539;179474538
N2AB1556346912;46913;46914 chr2:178609813;178609812;178609811chr2:179474540;179474539;179474538
N2A1463644131;44132;44133 chr2:178609813;178609812;178609811chr2:179474540;179474539;179474538
N2B813924640;24641;24642 chr2:178609813;178609812;178609811chr2:179474540;179474539;179474538
Novex-1826425015;25016;25017 chr2:178609813;178609812;178609811chr2:179474540;179474539;179474538
Novex-2833125216;25217;25218 chr2:178609813;178609812;178609811chr2:179474540;179474539;179474538
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: I
  • RefSeq wild type transcript codon: ATC
  • RefSeq wild type template codon: TAG
  • Domain: Fn3-13
  • Domain position: 58
  • Structural Position: 88
  • Q(SASA): 0.3933
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
I/V rs1383602491 -0.64 None N 0.107 0.061 0.319402600006 gnomAD-3.1.2 6.59E-06 None None None None I None 0 0 0 0 0 None 0 0 1.47E-05 0 0
I/V rs1383602491 -0.64 None N 0.107 0.061 0.319402600006 gnomAD-4.0.0 1.8601E-06 None None None None I None 0 0 None 0 0 None 0 0 2.54395E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
I/A 0.2701 likely_benign 0.2358 benign -1.46 Destabilizing 0.035 N 0.294 neutral None None None None I
I/C 0.6345 likely_pathogenic 0.6027 pathogenic -0.947 Destabilizing 0.555 D 0.345 neutral None None None None I
I/D 0.6199 likely_pathogenic 0.5732 pathogenic -1.305 Destabilizing 0.555 D 0.406 neutral None None None None I
I/E 0.5701 likely_pathogenic 0.5231 ambiguous -1.249 Destabilizing 0.555 D 0.393 neutral None None None None I
I/F 0.1842 likely_benign 0.1725 benign -0.973 Destabilizing 0.117 N 0.299 neutral N 0.440500808 None None I
I/G 0.421 ambiguous 0.3747 ambiguous -1.762 Destabilizing 0.262 N 0.379 neutral None None None None I
I/H 0.5164 ambiguous 0.4855 ambiguous -0.713 Destabilizing 0.935 D 0.363 neutral None None None None I
I/K 0.4822 ambiguous 0.4594 ambiguous -1.007 Destabilizing 0.262 N 0.394 neutral None None None None I
I/L 0.0931 likely_benign 0.088 benign -0.682 Destabilizing None N 0.086 neutral N 0.422915125 None None I
I/M 0.1023 likely_benign 0.0989 benign -0.743 Destabilizing 0.317 N 0.375 neutral N 0.424261919 None None I
I/N 0.2189 likely_benign 0.1945 benign -1.14 Destabilizing 0.741 D 0.403 neutral N 0.398728756 None None I
I/P 0.8781 likely_pathogenic 0.853 pathogenic -0.915 Destabilizing 0.555 D 0.413 neutral None None None None I
I/Q 0.4408 ambiguous 0.4116 ambiguous -1.231 Destabilizing 0.791 D 0.393 neutral None None None None I
I/R 0.4407 ambiguous 0.4178 ambiguous -0.457 Destabilizing 0.555 D 0.401 neutral None None None None I
I/S 0.2245 likely_benign 0.2014 benign -1.634 Destabilizing 0.117 N 0.384 neutral N 0.345030344 None None I
I/T 0.2366 likely_benign 0.2078 benign -1.458 Destabilizing 0.027 N 0.295 neutral N 0.381545718 None None I
I/V 0.0667 likely_benign 0.0646 benign -0.915 Destabilizing None N 0.107 neutral N 0.371198225 None None I
I/W 0.8354 likely_pathogenic 0.8234 pathogenic -1.07 Destabilizing 0.935 D 0.389 neutral None None None None I
I/Y 0.5255 ambiguous 0.4887 ambiguous -0.812 Destabilizing 0.555 D 0.376 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.